Old West Investment Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-1,068,719
| Closed | -$3.63M | – | 90 |
|
2018
Q3 | $3.63M | Buy |
1,068,719
+2,918
| +0.3% | +$9.92K | 1.5% | 21 |
|
2018
Q2 | $4.01M | Buy |
1,065,801
+444,415
| +72% | +$1.67M | 2.01% | 18 |
|
2018
Q1 | $2.54M | Sell |
621,386
-188
| -0% | -$769 | 1.46% | 25 |
|
2017
Q4 | $2.89M | Sell |
621,574
-89,338
| -13% | -$415K | 1.65% | 23 |
|
2017
Q3 | $5.05M | Sell |
710,912
-74,924
| -10% | -$532K | 2.65% | 14 |
|
2017
Q2 | $5.68M | Sell |
785,836
-43,078
| -5% | -$311K | 3.03% | 8 |
|
2017
Q1 | $5.11M | Buy |
828,914
+619,285
| +295% | +$3.81M | 2.71% | 13 |
|
2016
Q4 | $1.23M | Buy |
209,629
+73,405
| +54% | +$430K | 0.75% | 29 |
|
2016
Q3 | $723K | Buy |
136,224
+9,994
| +8% | +$53K | 0.53% | 38 |
|
2016
Q2 | $835K | Sell |
126,230
-1,390
| -1% | -$9.2K | 0.61% | 33 |
|
2016
Q1 | $595K | Buy |
127,620
+65,701
| +106% | +$306K | 0.5% | 40 |
|
2015
Q4 | $312K | Sell |
61,919
-15,485
| -20% | -$78K | 0.28% | 59 |
|
2015
Q3 | $272K | Sell |
77,404
-2,263
| -3% | -$7.95K | 0.21% | 64 |
|
2015
Q2 | $795K | Buy |
79,667
+36,326
| +84% | +$362K | 0.55% | 47 |
|
2015
Q1 | $551K | Buy |
43,341
+23,925
| +123% | +$304K | 0.37% | 64 |
|
2014
Q4 | $274K | Buy |
19,416
+418
| +2% | +$5.9K | 0.17% | 77 |
|
2014
Q3 | $261K | Buy |
+18,998
| New | +$261K | 0.16% | 76 |
|